Novel treatments in pipeline for diabetic eye disease

Article
Conference|AAO

Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.


Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!
Recent Videos
At EURETINA 2025, Stela Vujosevic, MD, PhD, FEBO asks, "as part of the symposium on diabetes and vascular disease, "Do we need a new staging for diabetic retinopathy and macular edema?"
Ursula Schmidt-Erfurth, MD, Professor of Ophthalmology at the Medical University of Vienna, Austria, discusses her keynote EURETINA Lecture, artificial intelligence and age-related macular degeneration.
Related Content
Belite Bio concludes phase 3 DRAGON study for Stargardt disease

Belite Bio concludes phase 3 DRAGON study for Stargardt disease

Kassi Filkins
September 17th 2025
Article
Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Alex Delaney-Gesing ;David Hutton
September 17th 2025
Podcast
New study examines soft drusen regression without atrophy and drusen ooze

New study examines soft drusen regression without atrophy and drusen ooze

Lynda Charters
September 17th 2025
Article
What to expect from virtual AAO 2020

What to expect from virtual AAO 2020

Alex Delaney-Gesing
September 17th 2025
Podcast
Study links AMD to higher cardiovascular disease mortality in high-risk patients

Study links AMD to higher cardiovascular disease mortality in high-risk patients

Lynda Charters
September 17th 2025
Article
Diabetic retinopathy in pregnancy

Diabetic retinopathy in pregnancy

Kassi Filkins
September 17th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.